|
Brenner & Rector's The Kidney, 7th ed. Saunders 2004; pp.2118-2119. Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology.Circulation 2000; 101 (3): 329–35. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42 (6): 1206–52. Elberg, G., Gimble, J. M., and Tsai, S. Y. Modulation of the murine peroxisome proliferator-activated receptor gamma 2 promoter activity by CCAAT/enhancer-binding proteins. J Biol Chem 275 2000; 27815-27822. Engeli S, Bohnke J, Gorzelniak K et al. Weight loss and the renin–angiotensin–aldosterone system. Hypertension 2005; 45: 356–362 Eriksson, J. W., Smith, U., Waagstein, F., Wysocki, M., and Jansson, P. A. (). Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes 48 1999; 1572-1578. Faust, I. M., Johnson, P. R., Stern, J. S., and Hirsch, J. Diet-induced adipocyte number increase in adult rats: a new model of obesity. Am J Physiol 235 1978; E279-286. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002; 288: 1758–61 Fujino T, Nakagawa N, Yuhki K, et al. Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP. J. Clin. Invest. 2004; 114 (6): 805–12. Green, H. and Meuth, M. An established pre-adipose cell line and its differentiation in culture. Cell 1974; 3(2):127-133. Guyton & Hall. Textbook of Medical Physiology (7th ed.).Elsevier-Saunders. 2005;pp. 220. Hall JE, Brands MW, Dixon WN, et al. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension. 1993;22:292-299. Hall JE, Zappe DH, Alonso-Galicia M, et al. Mechanisms of obesity-induced hypertension. News Physiol Sci. 1996;11:255-261. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223 Krause RM, Winston M, Fletcher BJ, Grundy SM. Obesity. Impact on cardiovascular disease. Circulation 1998; 98: 1472–1476 Nguyen G, Delarue F, Burckl�� C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin..J. Clin. Invest 2002;109 (11): 1417–27. Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension.Ann. Intern. Med. 2003;139 (9): 761–76. Pratt RE, Flynn JA, Hobart PM, Paul M, Dzau VJ. Different secretory pathways of renin from mouse cells transfected with the human renin gene. J. Biol. Chem. 1988;263 (7): 3137–41. Thompson D, Edelsberg J, Colditz GA, Bird AP, Oster G. Lifetime health and economic consequences of obesity. Archives of Internal Medicine 1999; 159: 2177–83
|